1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow Medical Enterprises Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumors. Synergo® RITE + MMC - Bladder Cancer, Bladder Neoplasm | Phase 3 | Terminated | Medical Enterprises Ltd. | 5 | 2019-04-04 | 2020-04-15 |
Disease (1) · Urinary Bladder Neoplasms (1)
Mitomycin (1)
United States (1)